https://tie2-receptor.com/mult....iple-screening-regar
The biomimetic nanoplatform, leveraging hybrid membranes consisting of mesenchymal stem cell membranes (MSCm) and pH-responsive liposomes (pSL), exhibits the capacity to specifically target the tumor microenvironment (TME) and escape the endo/lysosomal system after endocytic internalization. The 4T1 xenograft model results show HM-BPT treatment effectively inhibits tumors,
처럼
논평
공유하다
